SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-083003
Filing Date
2015-12-02
Accepted
2015-12-02 19:04:27
Documents
1
Period of Report
2015-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4481
  Complete submission text file 0001209191-15-083003.txt   5851
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3344 N. TORREY PINES COURT LA JOLLA CA 92037
Business Address
Lynch Thomas P. (Reporting) CIK: 0001659824 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 151265965